IndraLab
Statements
sparser
"MCL1 WT and S159D mutant (which is a phosphomimetic mutant in the GSK3β phosphorylation site), but not MCL1 S159A mutant (which abolished phosphorylation by GSK-3), substantially decreased the interaction between JOSD1 and MCL-1 in the presence of IR in CAL27R cells (Fig. xref )."
reach
"TRAF4 promoted Akt K63-linked ubiquitination and activation to suppress GSK3β activity and MCL-1 S159 phosphorylation, facilitating the interaction between MCL-1 and JOSD1, which ultimately promoted the stability and expression of MCL-1 to confer resistance to radiotherapy in OSCC cells (Fig. 7G)."
sparser
"TRAF4 promoted Akt K63-linked ubiquitination and activation to suppress GSK3β activity and MCL-1 S159 phosphorylation, facilitating the interaction between MCL-1 and JOSD1, which ultimately promoted the stability and expression of MCL-1 to confer resistance to radiotherapy in OSCC cells (Fig. xref )."
sparser
"TRAF4 knockout inhibited the phosphorylation of Akt and upregulated GSK3β activity, resulting in increased myeloid cell leukemia-1 (MCL-1) S159 phosphorylation, which disrupted the interaction of MCL-1 with Josephin domain containing 1 (JOSD1), and ultimately induced MCL-1 ubiquitination and degradation."